Earnings History Data for Amphastar Pharmaceuticals, Inc. (AMPH) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
08-11-2023	AH		AMPH	Amphastar Pharmaceuticals, Inc.	2,290	1.08	0.67	0.32	Amphastar Pharmaceuticals Non-GAAP EPS of $1.15 beats by $0.46, revenue of $180.6M beats by $6.8M [11/8/2023 5:22 PM]	52.45	7.03 (15.49%)	48.07	2.65 (5.83%)	27.00 - 67.66	888,067	300,000	14,431
Amphastar Pharmaceuticals Non-GAAP EPS of $1.15 beats by $0.46, revenue of $180.6M beats by $6.8M [11/8/2023 5:22 PM]
08-08-2023	AH		AMPH	Amphastar Pharmaceuticals, Inc.	3,030	0.58	0.52	0.33	Amphastar Pharmaceuticals Non-GAAP EPS of $0.65 beats by $0.09, revenue of $145.7M beats by $8.73M [8/8/2023 4:37 PM]	62.40	-2.60 (-4.00%)	65.90	0.90 (1.38%)	26.76 - 67.66	796,886	270,000	468
Amphastar Pharmaceuticals Non-GAAP EPS of $0.65 beats by $0.09, revenue of $145.7M beats by $8.73M [8/8/2023 4:37 PM]
09-05-2023	AH	After the close (May 9)	AMPH	Amphastar Pharmaceuticals, Inc.	1,760	0.52	0.40	0.47	Amphastar Pharmaceuticals Non-GAAP EPS of $0.62 beats by $0.13, revenue of $140M beats by $4.37M [5/9/2023 4:56 PM]	41.21	4.77 (13.09%)	36.44	0.0 (0.00%)	26.76 - 44.15	545,356	380,000	13,238
Amphastar Pharmaceuticals Non-GAAP EPS of $0.62 beats by $0.13, revenue of $140M beats by $4.37M [5/9/2023 4:56 PM]
28-02-2023	AH	After the close (Feb 28)	AMPH	Amphastar Pharmaceuticals, Inc.	1,550	0.67	0.34	0.42	Amphastar Pharmaceuticals Non-GAAP EPS of $0.73 beats by $0.33, revenue of $135M beats by $8.26M [2/28/2023 4:46 PM]	36.53	4.67 (14.66%)	33.20	1.34 (4.21%)	26.76 - 44.46	698,178	240,000	19,730
Amphastar Pharmaceuticals Non-GAAP EPS of $0.73 beats by $0.33, revenue of $135M beats by $8.26M [2/28/2023 4:46 PM]
07-11-2022	AH	4:05 PM ET (Nov 7)	AMPH	Amphastar Pharmaceuticals, Inc.	1,460	0.32	0.32	0.46	Amphastar Pharmaceuticals Non-GAAP EPS of $0.38 misses by $0.01, revenue of $120.13M misses by $6.27M [11/7/2022 4:32 PM]	27.23	-2.87 (-9.52%)	27.18	-2.92 (-9.70%)	19.21 - 44.46	415,692	200,000	3,613
Amphastar Pharmaceuticals Q3 2022 Earnings Preview [11/7/2022 12:40 AM] Amphastar Pharmaceuticals Non-GAAP EPS of $0.38 misses by $0.01, revenue of $120.13M misses by $6.27M [11/7/2022 4:32 PM] Amphastar authorizes $50M buyback [11/8/2022 2:16 AM] Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2022 [Nov-07-22 04:05PM] Amphastar Pharmaceuticals (AMPH) Q3 Earnings Meet Estimates [Nov-07-22 05:45PM]
08-08-2022	AH		AMPH	Amphastar Pharmaceuticals, Inc.	1,760	0.33	0.30	0.21	Amphastar Pharmaceuticals Non-GAAP EPS of $0.39 beats by $0.04, revenue of $123.47M beats by $5.59M [8/8/2022 4:50 PM]	32.00	-5.75 (-15.24%)	38.17	0.42 (1.11%)	17.56 - 44.46	1,227,389	280,000	306
Amphastar Pharmaceuticals Non-GAAP EPS of $0.39 beats by $0.04, revenue of $123.47M beats by $5.59M [8/8/2022 4:50 PM] Amphastar sheds 14% after announcing FDA rejection of generic drugs [8/9/2022 12:11 PM] Amphastar, Syndax Top Second-Quarter Estimates, But Runaway Biotechs At A Standstill [Aug-08-22 04:34PM] Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2022 [Aug-08-22 04:05PM]
09-05-2022	AH		AMPH	Amphastar Pharmaceuticals, Inc.	1,660	0.47	0.33	0.27	Amphastar Pharmaceuticals Non-GAAP EPS of $0.47, revenue of $120.4M [5/9/2022 5:00 PM]	33.98	2.22 (6.99%)	31.76	0.0 (0.00%)	17.56 - 44.46	628,078	440,000	89,509
Amphastar Pharmaceuticals Non-GAAP EPS of $0.47, revenue of $120.4M [5/9/2022 5:00 PM] Amphastar Feels the Big Money Love [May-09-22 07:48AM] Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2022 [May-09-22 04:05PM] Amphastar Pharmaceuticals (AMPH) Q1 Earnings and Revenues Top Estimates [May-09-22 06:05PM] Amphastar Pharmaceuticals (AMPH) Q1 2022 Earnings Call Transcript [May-10-22 05:00AM]
10-03-2022	AH		AMPH	Amphastar Pharmaceuticals, Inc.	1,430	0.42	0.38	0.16	Amphastar Pharmaceuticals Non-GAAP EPS of $0.42 beats by $0.05, revenue of $120.9M beats by $9.28M [3/10/2022 4:42 PM]	34.23	3.76 (12.34%)	30.47	0.0 (0.00%)	16.91 - 34.96	1,145,583	450,000	66,692
Amphastar Pharmaceuticals Non-GAAP EPS of $0.42 beats by $0.05, revenue of $120.9M beats by $9.28M [3/10/2022 4:42 PM] Amphastar climbs after Q4 beat as Piper Sandler raises target to a Street high [3/11/2022 11:41 AM] Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2021 [Mar-10-22 04:05PM] Amphastar Pharmaceuticals (AMPH) Tops Q4 Earnings and Revenue Estimates [Mar-10-22 05:55PM] Amphastar Pharmaceuticals (AMPH) Q4 2021 Earnings Call Transcript [Mar-10-22 10:00PM]
08-11-2021	AH		AMPH	Amphastar Pharmaceuticals, Inc.	949.11	0.46	0.22	0.09	Amphastar Pharmaceuticals EPS beats by $0.23, beats on revenue [11/8/2021 4:54 PM]	20.77	0.82 (4.11%)	20.33	0.38 (1.90%)	16.91 - 21.63	436,002	130,000	522
Amphastar Pharmaceuticals EPS beats by $0.23, beats on revenue [11/8/2021 4:54 PM] Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2021 [Nov-08-21 04:24PM] Amphastar Pharmaceuticals (AMPH) Q3 Earnings and Revenues Beat Estimates [Nov-08-21 06:35PM] Amphastar Pharmaceuticals, inc (AMPH) Q3 2021 Earnings Call Transcript [Nov-08-21 10:00PM]
09-08-2021	AH		AMPH	Amphastar Pharmaceuticals, Inc.	969.38	0.21	0.21	0.16	Amphastar Pharmaceuticals EPS in-line, beats on revenue [8/9/2021 4:38 PM]	20.33	0.25 (1.25%)	20.08	0.0 (0.00%)	16.91 - 21.63	126,913	220,000	4,464
Amphastar Pharmaceuticals EPS in-line, beats on revenue [8/9/2021 4:38 PM] Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2021 [Aug-09-21 04:05PM] Amphastar Pharmaceuticals (AMPH) Meets Q2 Earnings Estimates [Aug-09-21 06:45PM] Amphastar Pharmaceuticals, inc (AMPH) Q2 2021 Earnings Call Transcript [Aug-09-21 08:30PM]
06-05-2021	AH	4:05 PM ET (May 6)	AMPH	Amphastar Pharmaceuticals, Inc.	864.62	0.27	0.19	0.17	Amphastar Pharmaceuticals EPS beats by $0.09, beats on revenue [5/6/2021 4:30 PM]	18.72	0.67 (3.71%)	18.77	0.72 (3.99%)	16.91 - 22.69	190,211	140,000	8,370
Amphastar Pharmaceuticals EPS beats by $0.09, beats on revenue [5/6/2021 4:30 PM] Amphastar to restructure its Chinese subsidiaries [5/7/2021 4:34 PM] Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2021 [May-06-21 04:05PM] Amphastar Pharmaceuticals (AMPH) Q1 Earnings and Revenues Top Estimates [May-06-21 06:25PM] Amphastar Pharmaceuticals Inc (AMPH) Q1 2021 Earnings Call Transcript [May-07-21 10:00AM] Amphastar Announces Buyback of 26% of the Equity in its ANP Subsidiary and Spin-off its Hanxin Subsidiary [May-07-21 04:05PM]
15-03-2021	AH	4:05 PM ET (Mar 15)	AMPH	Amphastar Pharmaceuticals, Inc.	904.48	0.16	0.14	0.07	Amphastar Pharmaceuticals EPS beats by $0.02, beats on revenue [3/15/2021 4:14 PM]	18.37	-0.78 (-4.07%)	19.88	1.75 (9.65%)	12.32 - 22.69	185,328	319,665	0
Amphastar Pharmaceuticals EPS beats by $0.02, beats on revenue [3/15/2021 4:14 PM] Amphastar Pharmaceuticals, Inc. to Host Earnings Call [Mar-15-21 02:45AM] Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2020 [Mar-15-21 04:05PM] Amphastar Pharmaceuticals (AMPH) Surpasses Q4 Earnings and Revenue Estimates [Mar-15-21 05:35PM] Recap: Amphastar Pharmaceuticals Q4 Earnings [Mar-15-21 05:00PM] Amphastar Pharmaceuticals Inc (AMPH) Q4 2020 Earnings Call Transcript [Mar-15-21 08:30PM]
06-11-2020	PM	0:00 AM ET (Nov 6)	AMPH	Amphastar Pharmaceuticals, Inc.	984.85	0.09	0.13	0.10	Amphastar Pharmaceuticals EPS beats by $0.01, misses on revenue [11/6/2020 6:53 AM]	19.18	-1.45 (-7.03%)	20.63	0.0 (0.00%)	12.32 - 22.69	214,464	143,270	1,391

06-08-2020	AH	4:05 PM ET (Aug 6)	AMPH	Amphastar Pharmaceuticals, Inc.	958.15	0.16	0.11	0.08	Amphastar Pharmaceuticals EPS beats by $0.02, misses on revenue [8/6/2020 4:16 PM]	20.38	0.10 (0.52%)	18.52	-1.75 (-8.63%)	12.32 - 22.85	111,185	226,781	405